Systemic co-treatment with α-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs

Hearing Research

Volumn 179, Issue 1-2, 2003, Pages 53-61

  Wolters, Francisca L C ^a   Klis, Sjaak F L ^a   De Groot, John C M J ^a   Hamers, Frank P T ^a   Prieskorn, Diane M ^b   Miller, Josef M ^b   Smoorenburg, Guido F ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Cisplatin ototoxicity; Cochlea; Compound action potential; Deafness; Mini osmotic pump; Protection; MSH

Indexed keywords

ALPHA INTERMEDIN; CISPLATIN;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL LOSS; CELL PROTECTION; COCHLEA FENESTRA; CONTROLLED STUDY; DRUG EFFECT; ELECTROCOCHLEOGRAPHY; ELECTRODE; FEMALE; GUINEA PIG; HAIR CELL; HEARING LOSS; HISTOPATHOLOGY; NONHUMAN; OSMOTIC MINIPUMP; OTOTOXICITY; PRIORITY JOURNAL; SOUND INTENSITY;

EID: 0037962793     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(03)00080-7     Document Type: Article

References (39)

1. Campbell K.C.M., Meech R.P., Rybak L.P., Hughes L.F. D-Methionine protects against cisplatin damage to the stria vascularis. Hear. Res. 138:1999;13-28.
2. Cappaert N.L.M., Klis S.F.L., Muijser H., Kulig B.M., Smoorenburg G.F. Simultaneous exposure to ethyl benzene and noise: synergistic effects on outer hair cells. Hear. Res. 162:2001;67-79.
3. Cardinaal R.M., De Groot J.C.M.J., Huizing E.H., Veldman J.E., Smoorenburg G.F. Dose-dependent effect of 8-day cisplatin administration upon the morphology of the guinea pig cochlea. Hear. Res. 144:2000;135-146.
4. Cardinaal R.M., De Groot J.C.M.J., Huizing E.H., Veldman J.E., Smoorenburg G.F. Cisplatin-induced ototoxicity: morphological evidence of spontaneous outer hair cell recovery in albino guinea pigs. Hear. Res. 144:2000;147-156.
5. (4-9) analogue, ORG 2766, on cisplatin ototoxicity in albino guinea pigs. Hear. Res. 144:2000;157-167.
6. Clerici W.J., Hensley K., DiMartino D.L., Butterfield D.A. Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear. Res. 98:1996;116-124.
7. De Groot J.C.M.J., Veldman J.E., Huizing E.H. An improved fixation method for guinea pig cochlear tissues. Acta Otolaryngol. (Stockh.). 104:1987;234-242.
8. (4-9) analogue, ORG 2766, may reduce the cochleotoxic effects of cisplatin. Hear. Res. 106:1997;9-19.
9. Ekborn A., Laurell G., Jonhström P., Wallin I., Eksborg S., Ehrsson H. D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics. Hear. Res. 165:2002;53-61.
10. Greenwood D.D. Comparing octaves, frequency ranges, and cochlear-map curvature across species. Hear. Res. 94:1996;157-162.
11. (4-9) analog to affect cisplatin ototoxicity: an electrocochleographic study in guinea pigs. Eur. Arch. Otorhinolaryngol. 251:1994;23-29.
12. Heijmen P.S., Klis S.F.L., De Groot J.C.M.J., Smoorenburg G.F. Cisplatin ototoxicity and the possibly protective effect of α-melanocyte stimulating hormone. Hear. Res. 128:1999;27-39.
13. Hilding D.A., Ginzberg R.D. Pigmentation of the stria vascularis. The contribution of neural crest melanocytes. Acta Otolaryngol. (Stockh.). 84:1977;24-37.
14. Hoeve L.J., Mertens zur Borg I.R.A.M., Rodenburg M., Brocaar M.P., Groen B.G.S. Correlations between cis-platinum dosage and toxicity in a guinea pig model. Arch. Otorhinolaryngol. 245:1988;98-102.
15. Klis S.F.L., O'Leary S.J., Hamers F.P.T., De Groot J.C.M.J., Smoorenburg G.F. Reversible cisplatin ototoxicity in the albino guinea pig. NeuroReport. 11:2000;623-626.
16. Klis S.F.L., O'Leary S.J., Wijbenga J., De Groot J.C.M.J., Hamers F.P.T., Smoorenburg G.F. Partial recovery of cisplatin-induced hearing loss in the albino guinea pig in relation to cisplatin dose. Hear. Res. 164:2002;138-146.
17. Kohn S., Fradis M., Pratt H., Zidan J., Podoshin L., Robinson E., Nir I. Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis. Laryngoscope. 98:1988;865-871.
18. Kohn S., Fradis M., Podoshin L., Ben-David J., Zidan J., Robinson E. Endothelial injury of capillaries in the stria vascularis of guinea pigs treated with cisplatin and gentamicin. Ultrastruct. Pathol. 21:1997;289-299.
19. Komune S., Asakuma S., Snow J.B.J. Pathophysiology of the ototoxicity of cis diamminedichloroplatinum. Otolaryngol. Head Neck Surg. 89:1981;275-282.
20. Kopke R.D., Liu W., Gabaizadeh R., Jacono A., Feghali J., Spray D., Garcia P., Steinman H., Malgrange B., Ruben R.J., Rybak L.P., Van De Water T.R. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. Am. J. Otolaryngol. 18:1997;559-571.
21. Li G., Frenz D.A., Brahmblatt S., Feghali J.G., Ruben R.J., Berggren D., Arezzo J., Van De Water T.R. Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy. Neurotoxicology. 22:2001;163-176.
22. Li G., Sha S.H., Zotova E., Arezzo J., Van De Water T., Schacht J. Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action. Lab. Invest. 82:2002;585-596.
23. Meech R.P., Campbell K.C.M., Hughes L.P., Rybak L.P. A semiquantative analysis of the effects of cisplatin on the rat stria vascularis. Hear. Res. 124:1998;44-59.
24. Meyer zum Gottesberge, A.M., 2000. Hormonal regulation of the inner ear. In: Sterkers, O., Ferrary, E., Dauman, R., Sauvage, J.P., Tran Ba Huy, P. (Eds.), Menière's Disease 1999 - Update. Kugler Publications, The Hague, pp. 49-57.
25. Motohashi H., Hozawa K., Oshima T., Takeuchi T., Takasaka T. Dysgenesis of melanocytes and cochlear dysfunction in mutant microphthalmia (mi) mice. Hear. Res. 80:1994;10-20.
26. Nakai Y., Konishi K., Chang K.C., Ohashi K., Morisaki N., Minowa Y., Morimoto A. Ototoxicity of the anticancer drug cisplatin. Acta Otolaryngol. (Stockh.). 93:1982;227-232.
27. O'Leary S.J., Klis S.F.L., De Groot J.C.M.J., Hamers F.P.T., Smoorenburg G.F. Perilymphatic application of cisplatin over several days in albino guinea pigs: dose dependency of electrophysiological and morphological effects. Hear. Res. 154:2001;135-145.
28. Prieskorn D.M., Miller J.M. Technical report: Chronic and acute intra-cochlear infusion in rodents. Hear. Res. 140:2000;212-215.
29. Reser D.H., Rho M., Dewan D., Herbst L., Li G., Stupak H., Zur K., Romaine J., Frenz D., Goldbloom L., Kopke R., Arezzo J., Van De Water T.R. L- and D-methionine provide equivalent long-term protection against CDDP-induced ototoxicity in vivo, with partial in vitro and in vivo retention of antineoplastic activity. Neurotoxicology. 20:1999;731-748.
30. Rybak L.P., Ravi R., Somani S.M. Mechanism of protection by diethyldithio-carbamate against cisplatin ototoxicity: Antioxidant system. Fundam. Appl. Toxicol. 26:1995;293-300.
31. Rybak L.P., Whitworth C., Somani S.M. Application of antioxidants and other agents to prevent cisplatin ototoxicity. Laryngoscope. 109:1999;1740-1744.
32. Saito T., Aran J.M. Comparative ototoxicity of cisplatin during acute and chronic treatment. Otorhinolaryngology. 56:1994;315-320.
33. Schweitzer V.G. Cisplatin-induced ototoxicity: The effect of pigmentation and inhibitory agents. Laryngoscope. 103:1993;1-52.
34. Smoorenburg G.F., De Groot J.C.M.J., Hamers F.P.T., Klis S.F.L. Protection and spontaneous recovery from cisplatin-induced hearing loss. Ann. N.Y. Acad. Sci. 884:1999;192-210.
35. (4-9) analog on cisplatin ototoxicity in relation to the cisplatin dose: An electrocochleographic study in albino guinea pigs. Hear. Res. 124:1998;108-117.
36. Tange R.A. Differences in the cochlear degeneration pattern in the guinea pig as a result of gentamicin and cis-platinum intoxication. Clin. Otolaryngol. 9:1984;323-327.
37. Tange R.A., Vuzevski V.D. Changes in the stria vascularis of the guinea pig due to cisplatinum. Arch. Otorhinolaryngol. 239:1984;41-47.
38. Tsukasaki N., Whitworth C.A., Rybak L.P. Acute changes in cochlear potentials due to cisplatin. Hear. Res. 149:2000;189-198.
39. Zheng J.L., Gao W.Q. Differential damage to auditory neurons and hair cells by ototoxins and neuroprotection by specific neurotrophins in rat cochlear organotypic cultures. Eur. J. Neurosci. 8:1996;1897-1905.